Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 153,220Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Strides Pharma Science

02 3Bausch Health

03 1Boehringer Ingelheim GmbH

04 3IVAX Pharmaceuticals Inc

05 1NexGen Pharmaceuticals

06 1Synerlab

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info : DISCN

Registration Country : USA

PERGOLIDE MESYLATE

Brand Name : PERGOLIDE MESYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 0.05MG BASE

Packaging :

Approval Date : 2002-11-27

Application Number : 76061

Regulatory Info : DISCN

Registration Country : USA

Strides Pharma Science

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info : DISCN

Registration Country : USA

PERGOLIDE MESYLATE

Brand Name : PERGOLIDE MESYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 0.25MG BASE

Packaging :

Approval Date : 2002-11-27

Application Number : 76061

Regulatory Info : DISCN

Registration Country : USA

Strides Pharma Science

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info : DISCN

Registration Country : USA

PERGOLIDE MESYLATE

Brand Name : PERGOLIDE MESYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 1MG BASE

Packaging :

Approval Date : 2002-11-27

Application Number : 76061

Regulatory Info : DISCN

Registration Country : USA

Strides Pharma Science

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PERGOLIDE MESYLATE

Brand Name : PERMAX

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 0.05MG BASE

Packaging :

Approval Date : 1988-12-30

Application Number : 19385

Regulatory Info : DISCN

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PERGOLIDE MESYLATE

Brand Name : PERMAX

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 0.25MG BASE

Packaging :

Approval Date : 1988-12-30

Application Number : 19385

Regulatory Info : DISCN

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PERGOLIDE MESYLATE

Brand Name : PERMAX

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 1MG BASE

Packaging :

Approval Date : 1988-12-30

Application Number : 19385

Regulatory Info : DISCN

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PERGOLIDE (PERGOLIDE MESYLATE)

Brand Name : PRASCEND

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number : 2412217

Regulatory Info : Prescription

Registration Country : Canada

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PERGOLIDE MESYLATE

Brand Name : PERGOLIDE MESYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 0.05MG BASE

Packaging :

Approval Date : 2003-09-04

Application Number : 76094

Regulatory Info : DISCN

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PERGOLIDE MESYLATE

Brand Name : PERGOLIDE MESYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 0.25MG BASE

Packaging :

Approval Date : 2003-09-04

Application Number : 76094

Regulatory Info : DISCN

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PERGOLIDE MESYLATE

Brand Name : PERGOLIDE MESYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 1MG BASE

Packaging :

Approval Date : 2003-09-04

Application Number : 76094

Regulatory Info : DISCN

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Pergolide Mesylate

Brand Name :

Dosage Form : Suspension

Dosage Strength : 1.5MG/1ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : U.S.A

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Pergolide Mesylate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.05MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : France

blank